Recent content from Joe Carlson
Roseville-based Rebiotix launched a clinical trial this month to test its treatment for C. diff infections.
State high court gives OK for shareholders to proceed.
Judge ruled the test results are products of the laws of nature, can't be patented.
Minnetonka-based Osprey Medical has raised about $26 million to bolster its U.S. sales force and ramp up efforts to sell medical devices that reduce the…
The device can provide data on heart performance in about 20 minutes at a cost of $100 or less.
With a national debate raging, Leigh Turner has taken center stage in questioning whether many of these services are legitimate.
Miromatrix is developing a process that transforms pig livers for use in humans through "reseeding" a white collagen shell.
The previously announced deal involves lower-margin products widely used in hospitals.
Although the company said the concept shows promise, it's opted to pursue other priorities.
Medical surgical supply sales offset slower growth in implantable devices, the company reported.
"Pops! one" would allow for glucose-level testing on the go, with just a tiny stick.
The two were working together months before the nearly $30B sale was finalized in January.
Profit still expected to hit low end of forecast for the May-through-July period.
Focus will be on new therapies for rare illnesses.
U.S. House measure would allow more time for them to be sent to the FDA.
Acquisition of Spirox could bolster its growth this year by 8 percentage points.
Stemonix products allow doctors to see how drugs and human cells react without risking a person's health.
Laura Brod has trod an unusual path into biotech, so perhaps it's not surprising that the company she leads is charting an unorthodox route.
Medtronic did not release figures for the confidential settlements. The company reported that it set aside $300 million for all of its legal settlements in the fiscal year that ended in April, according to the Securities and Exchange Commission filing.
Medtronic computers had been out for a full week, disrupting operations.
Costs would spike for 66,000 if Children's and Blue Cross can't agree.
Minnesota is a big player in the growing market for tools that are less invasive.
No patient harm reported from products made by Minn.'s Vascular Solutions.
A global computer outage has hurt Medtronic's ability to fulfill orders.
Blue Cross customers will not be covered there if no deal is reached by July 5.
Eden Prairie company, new partner to have a catalog of 7,000 products based in Twin Cities.
Incident happened hours after dueling protests over Islam.
In a push to increase use of its Tyrx envelope, company vows to share replacement cost should an infection set in.
Dr. Uzma Samadani is nearing a way to assess functions in real time.
India's government has ordered a big price cut; device firms are threatening to leave.
A Minneapolis firm's device is designed to help people sidelined with nerve damage regain the ability to walk
The medical device giant's guidance for year ahead is viewed by some as conservative.
The deaths occurred after patients tried to perform routine maintenance on their HeartMate II blood pump, made by the former St. Jude Medical. A "recall" notice urges that the upgrades be done in a clinic or hospital.
Hospital and medical device experts say well-meaning agencies did not coordinate attempts to provide — or always provide the most useful — information.
Experts will look to make recommendations to protect medical devices.
Patients with complex cardiac cases may benefit most from Acist Medical Systems device.
The trial between Boston Scientific and Medtronic minimally-invasive valves hints at a more competitive market.
Minnesota's IT experts had a tense and busy weekend.
Self-described whistleblower Muddy Waters accuses firm of trying to silence its critics.
Medtronic implant detects atrial fibrillation in high-risk patients.
The companies presented the results on heart devices at a Chicago conference.
Christopher M. Barry took design files to his new company when he left Lutonix.
Abbott's stimulation system can be controlled with an iPod, and is seen as the first big advancement in the U.S. in 20 years
After investing in the Maple Grove heart valve company in 2012, LivaNova is buying the company.
PraeVeni is working to implement what it calls a new test to accurately rule out the 10 most common heart problems for a fraction of the typical $4,000-plus cost of screening.
Recent FDA warning over seven patients implanted after recall could be a PR "black eye" for Abbott.
The company was faulted for failing to investigate defibrillator battery problems and cybersecurity shortcomings.
Mpls. hosted meeting to show off a brave new biotech world.
Valve was approved for use less than a year ago.
Medtronic's 670G device reads the blood-glucose level, makes a high-low prediction, then adjusts insulin dose.
Federal ruling might influence two separate whistleblower suits.
Minnesotan Nadim Yared was supposed to have one of his biggest jobs well underway just a few days into his new role as incoming chairman of the national medical-technology trade group AdvaMed.
Cardiovascular Systems Inc. was accused of hiding illegal sales tactics, but evidence was lacking.
The deal comes after the device maker halted sales of its Lotus heart valve.
But not all are sold on letting consumers purchase low-cost devices without a prescription.
The 10-year agreement is aimed at creating jointly held intellectual property.
Medtronic and St. Jude are rolling out upbeat trial results for key products.
Gillette Children's has designed a unit that helps kids recovering from surgery to move around on their own terms.
The Minnesota Department of Employment and Economic Development support is a $345,000 grant from its Job Creation Fund.
New programming makes the latest version of the device more accurate.
The plea is expected to allow Bryan Szweda to avoid jail time.
The company was already Minnesota's top biotech player. New management is thinking big.
The Lotus valve replacement system is for sale in Europe and under clinical testing in the U.S.
The medical device maker reaffirmed its full-year guidance, citing product launches in the current quarter.
The acquisition follows last year's $25 million financing round.
The FDA requires "postmarket" surveillance for medical devices. But researchers and regulators say the system is deeply flawed, exposing patients and doctors to greater risks.
Zift Medical, a startup in Fridley, believes its work can improve the process for having a brow lift
St. Jude Medical acquired the device in a 2015 deal and predicted it would be a key growth driver within five years.
Money in 2016 trailed off amid concern over fate of the Affordable Care Act.
Paul B. Pedersen was a boy of about 5, sitting next to the tar road near the family farmhouse in Ringsted, Iowa, when he had…
Adventium Labs is working on tools to help.
Medical device maker beat the forecasts, showed broad sales growth.
Regulatory approval to sell the device should boost sales and Abbott Laboratories' bottom line.
The open enrollment period to buy a 2017 health plan has been extended for one week.
David Clarke Jr. has been a popular pro-Trump commentator on Twitter and other media.
More from Star Tribune